275 related articles for article (PubMed ID: 32556891)
1. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma.
Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L
Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891
[TBL] [Abstract][Full Text] [Related]
2. Identification of a four-microRNA panel in serum for screening renal cell carcinoma.
Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264
[TBL] [Abstract][Full Text] [Related]
3. Combination of tumor suppressor miR-20b-5p, miR-30a-5p, and miR-196a-5p as a serum diagnostic panel for renal cell carcinoma.
Huang G; Li H; Wang J; Peng X; Liu K; Zhao L; Zhang C; Chen X; Lai Y; Ni L
Pathol Res Pract; 2020 Nov; 216(11):153152. PubMed ID: 32823234
[TBL] [Abstract][Full Text] [Related]
4. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma.
He T; Lu C; Gong W; Ge Z; Li R; Li X; Sun C; Li W; Long Q; Liu Q; Lai Y
Front Biosci (Landmark Ed); 2024 May; 29(5):186. PubMed ID: 38812297
[TBL] [Abstract][Full Text] [Related]
5. Urinary-derived extracellular vesicle microRNAs as non-invasive diagnostic biomarkers for early-stage renal cell carcinoma.
Zhang Y; Zhu YY; Chen Y; Zhang L; Wang R; Ding X; Zhang H; Zhang CY; Zhang C; Gu WJ; Wang C; Wang JJ
Clin Chim Acta; 2024 Jan; 552():117672. PubMed ID: 37995985
[TBL] [Abstract][Full Text] [Related]
6. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
Liu S; Deng X; Zhang J
Mol Med Rep; 2019 Dec; 20(6):5075-5083. PubMed ID: 31661117
[TBL] [Abstract][Full Text] [Related]
7. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O
J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013
[TBL] [Abstract][Full Text] [Related]
8. Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs.
Oto J; Herranz R; Plana E; Sánchez-González JV; Pérez-Ardavín J; Hervás D; Fernández-Pardo Á; Cana F; Vera-Donoso CD; Martínez-Sarmiento M; Medina P
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360679
[TBL] [Abstract][Full Text] [Related]
9. Profiling of Serum miRNAs Constructs a Diagnostic 3-miRNA Panel for Clear-Cell Renal Cell Carcinoma.
Li X; Wen Z; Li R; Lu C; Chen W; Chen X; Huang G; Ni L; Lai Y; Tao L
Clin Genitourin Cancer; 2024 Feb; 22(1):23-32. PubMed ID: 37574436
[TBL] [Abstract][Full Text] [Related]
10. A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
Wang C; Hu J; Lu M; Gu H; Zhou X; Chen X; Zen K; Zhang CY; Zhang T; Ge J; Wang J; Zhang C
Sci Rep; 2015 Jan; 5():7610. PubMed ID: 25556603
[TBL] [Abstract][Full Text] [Related]
11. A panel of three serum microRNA can be used as potential diagnostic biomarkers for nasopharyngeal carcinoma.
Li R; Lu C; Yang W; Zhou Y; Zhong J; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Hu H; Lai Y
J Clin Lab Anal; 2022 Feb; 36(2):e24194. PubMed ID: 35028969
[TBL] [Abstract][Full Text] [Related]
12. A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis.
Li R; Chen W; Lu C; Li X; Chen X; Huang G; Wen Z; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Ni L; Lai Y
Front Oncol; 2022; 12():1076303. PubMed ID: 36727070
[TBL] [Abstract][Full Text] [Related]
13. Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: a Meta-Analysis.
Chen Y; Wang X; Zhu X; Shao S
Clin Lab; 2018 Apr; 64(4):569-576. PubMed ID: 29739083
[TBL] [Abstract][Full Text] [Related]
14. A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma.
Li R; Lu C; Li X; Chen X; Huang G; Wen Z; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Lai Y
Front Genet; 2022; 13():897827. PubMed ID: 35938021
[No Abstract] [Full Text] [Related]
15. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
16. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.
Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y
Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801
[TBL] [Abstract][Full Text] [Related]
17. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
18. A Panel of Three Serum MicroRNAs as a Potential Diagnostic Biomarker for Urothelial Carcinoma.
Li H; Huang G; Lai Y; Ni L; Lai Y
Oncol Res Treat; 2022; 45(6):344-352. PubMed ID: 35231919
[TBL] [Abstract][Full Text] [Related]
19. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
